Bearbmagovva

Targeting programmed death ligand 1 for anticancer therapy using computational drug repurposing and molecular simulations

Furkejuvvon:
Publikašuvnnas:Scientific Reports (Nature Publisher Group) vol. 15, no. 1 (2025), p. 28742-28754
Váldodahkki: Khan, Mohd Shahnawaz
Eará dahkkit: Shamsi, Anas, Shahwan, Moyad, Dinislam, Khuzin, Yadav, Dharmendra Kumar
Almmustuhtton:
Nature Publishing Group
Fáttát:
Food & Drug Administration > FDA
Cancer
PD-L1 protein
Binders
Bioinformatics
Therapeutic targets
Binding sites
Biological products
Drug development
Computer applications
Molecular dynamics
Efficiency
Proteins
Simulation
Principal components analysis
FDA approval
Immune checkpoint
Antineoplastic drugs
Pharmacokinetics
Ligands
Immunosuppressive agents
Cancer therapies
Environmental
Liŋkkat:Citation/Abstract
Full Text
Full Text - PDF
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
Lasit vuosttaš kommeantta. Visot kommeanttat leat almmolaččat.!
Čálihuva vuohččan sisa